Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain

Completed · Not applicable · Has a placebo group

Conditions studied: Chronic Low Back Pain

In brief

The ActiPatch is a cutaneous device which is CE marked approved for relief of pain and has FDA clearance as an over the counter device for the adjunctive treatment of osteoarthritis of the knee and plantar fasciitis. It is taped over the affected area and stimulation at a high frequency is reported to alleviate pain with no sensation. By randomising patients between application of an active device or a dummy device and assessment of disability and pain scores at four weeks the efficacy or otherwise can be established. Chronic low back pain is a major health problem and if effective this has major economic implications as the device is cheap and safe.

Key facts

Study ID
NCT03240146
Run by
BioElectronics Corporation
People needed
60
Starts
2017-09-28
Expected to finish
2017-12-21
Last updated by the study team
2018-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.